ACOG Menu
Webinar

Prepare Your Clinics and Pregnant Patients for Fall and Winter Respiratory Virus Season

About the Webinar

As preparations for respiratory virus season this fall and winter begin, many health care professionals have questions about how to protect their patients and their families, themselves, and their colleagues against COVID-19, influenza, and RSV. Join Geeta K. Swamy, MD, FACOG, and CDC’s Dana Meaney-Delman, MD, MPH, FACOG, and Elisha Hall, PhD, RD, as they discuss vaccinations and other tools that can keep pregnant people safer this respiratory illness season.

Continuing education (CE) is available for a variety of professionals at https://www.train.org/cdctrain/welcome. CE credit expires September 23, 2024.

Download this CE resource sheet for more information.

Learning Objectives

  • Describe an emerging immunization issue

  • List a recent immunization recommendation made by the Advisory Committee on Immunization Practices

  • Locate current immunization resources to increase knowledge of team’s role in program implementation for improved team performance

Session-Specific Objectives

  • Describe how to prepare your clinics and patients for the 2024–25 fall and winter respiratory virus season

  • Identify the updated ACIP recommendations for flu, COVID-19, and RSV for pregnant people. 

  • Discuss how a strong recommendation for vaccination from a health care professional can protect patients this fall and winter respiratory virus season

Speakers
Geeta K. Swamy, MD, FACOG
Duke University School of Medicine

Geeta K. Swamy, MD, FACOG, is the Haywood Brown, MD, Distinguished Professor of Women’s Health in the Department of Obstetrics and Gynecology’s Division of Maternal–Fetal Medicine at Duke University. She also serves as associate vice president for research and executive vice dean for clinical sciences and research administration for Duke University and the Duke University School of Medicine. She is a nationally and internationally recognized clinician-researcher and leader in the field of perinatal infectious diseases and maternal immunization. She has led numerous vaccine trials in pregnant women with funding from the National Institutes of Health, Centers for Disease Control and Prevention (CDC), and industry sponsors. She currently serves as the co-principal investigator for Duke’s National Institute of Allergy and Infectious Diseases vaccine treatment and evaluation program and for the CDC-funded clinical immunization safety assessment project. Dr. Swamy is also a member of the U.S. Department of Health and Human Services’ National Vaccine Advisory Committee and ACOG’s Immunization, Infectious Disease, and Public Health Preparedness Expert Workgroup.

Dana Meaney-Delman, MD, MPH, FACOG

Dana Meaney-Delman is Branch Chief of the Infant Outcomes Monitoring, Research, and Prevention Branch within the National Center on Birth Defects and Developmental Disabilities at CDC. She served as the lead for maternal COVID-19 immunization efforts at the Centers for Disease Control and Prevention during the COVID-19 response and helped establish the COVID-19 v-safe pregnancy registry to rapidly collect data on pregnancy and infant outcomes following the initial release of COVID-19 vaccination.  She is the CDC liaison to ACOG’s Immunization, Infectious Disease, and Public Health Preparedness Expert Work Group.  As Branch Chief in the National Center for Birth Defects and Developmental Disabilities at the Centers for Disease Control and Prevention, Dr. Meaney-Delman and her dedicated team use surveillance and research data to provide clinical and public health recommendations for the care of women and infants with exposures. As a practicing ob-gyn, Dr. Meaney-Delman is passionate about ensuring the needs of pregnant women and infants are considered with all conditions and during all public health emergencies.

Elisha Hall

Elisha Hall, PhD, RD, is Senior Advisor for Vaccine Implementation with the Immunization Services Division within the National Center for Immunization and Respiratory Diseases at CDC. She has over a decade of leadership and technical experience in health education and training, research and evaluation, strategic planning, and coordination. Previously, she served on the COVID-19 response in various education and leadership roles within the Vaccine Task Force, including Clinical Guidelines Team Lead, where she led efforts to efficiently provide clinical guidance updates for the use COVID-19 vaccines in the United States. In her current role, she leads strategy and coordination of complex and high priority projects across the division, including vaccine policy implementation and maternal immunization.